Simplex Trading
AMLX icon

Simplex Trading’s Amylyx Pharmaceuticals AMLX Stock Holding History

Simplex Trading’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,727
Closed -$52.4K – 8969
2025
Q4 		$45K Buy
+3,727
New +$50.6K ﹤0.01% 5745
2025
Q2 		– Sell
-4,162
Closed -$20.2K – 8542
2025
Q1 		$14K Sell
4,162
-13,657
-77% -$48.6K ﹤0.01% 6823
2024
Q4 		$67K Sell
17,819
-93,909
-84% -$442K ﹤0.01% 5560
2024
Q3 		$361K Sell
111,728
-108,789
-49% -$245K ﹤0.01% 3938
2024
Q2 		$418K Buy
220,517
+138,410
+169% +$268K ﹤0.01% 3839
2024
Q1 		$233K Sell
82,107
-47,315
-37% -$619K ﹤0.01% 4678
2023
Q4 		$1.91M Buy
129,422
+106,870
+474% +$1.64M ﹤0.01% 2400
2023
Q3 		$412K Sell
22,552
-20,503
-48% -$434K ﹤0.01% 3604
2023
Q2 		$928K Buy
+43,055
New +$1.16M ﹤0.01% 2666
2023
Q1 		– Sell
-24,248
Closed -$842K – 8922
2022
Q4 		$895K Sell
24,248
-92,356
-79% -$3.28M ﹤0.01% 2567
2022
Q3 		$3.28M Sell
116,604
-41,486
-26% -$1.04M ﹤0.01% 1524
2022
Q2 		$3.04M Buy
158,090
+152,892
+2,941% +$1.82M ﹤0.01% 1490
2022
Q1 		$66K Buy
+5,198
New +$117K ﹤0.01% 6733

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Simplex Trading's AMLX Position: Q1 2026 in Review

Simplex Trading sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2026, closing a stake of 3,727 shares — an estimated $52.4K sold.

Simplex Trading first reported a position in AMLX in Q1 2022 and held it in 13 quarters. The position peaked at $3.28M in Q3 2022. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Simplex Trading reported no remaining Amylyx Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,727 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $52.4K.
  • Simplex Trading first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 13 quarters.
  • Simplex Trading's Amylyx Pharmaceuticals position peaked at $3.28M in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.